For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs "Not being on it is not an option." ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to access life-changing weight loss medications.

Last year she bought a compounding pharmacy's version of tirzepatide, paying about $470 monthly, and had lost more than 20 pounds when the FDA announced the ban on compounded weight-loss drugs.

Here’s the unglamorous truth that I’m hesitant to admit: The price tag is a commitment. Tirzepatide isn’t covered by insurance unless you qualify under certain medical conditions — diabetes, for ...

Study Overview: Eli Lilly and Company is conducting a clinical study titled ‘Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

Like semaglutide (Wegovy; Novo Nordisk), MariTide is a glucagon-like peptide-1 (GLP-1) agonist, and like tirzepatide (Zepbound; Eli Lilly), it has a second mechanism that relates to glucose-dependent ...

Saudi Arabia: A new review suggests that tirzepatide (Mounjaro, Zepbound) may have neuroprotective mechanisms that could help reduce the risk or progression of Alzheimer’s disease and dementia. The ...